Genomic Vision SA
PAR:GV

Watchlist Manager
Genomic Vision SA Logo
Genomic Vision SA
PAR:GV
Watchlist
Price: 0.0018 EUR
Market Cap: 694.6k EUR
No Transactions Found

We don't have any information about GV's insider trading.

Global
Insiders Monitor

Genomic Vision SA
Glance View

Market Cap
693.2k EUR
Industry
Biotechnology

Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The company is headquartered in Bagneux, Ile-De-France. The company went IPO on 2014-04-02. The company develops and commercializes single-DNA molecule diagnostic tests and research tools for life sciences, cancer and genetic diseases. The firm uses the molecular combining technique for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. The company develops its products and services in three main markets: the medical diagnostic market focusing on DNA diagnostics (cancer genomics, genetic diseases); the pharmaceutical research and development market in the fields of genomics, to develop tests that can help physicians identify how patients are likely to respond to targeted therapies (personalized medicine, pharmacogenomics, cancer cell proliferation); and the academic laboratories research market, providing molecular combining tools for academic research in the field of cancer genetics, cytogenetics and DNA replication.

GV Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top